palliative
treatment
nonresectable
lung
cancer
upper
hemibody
perfusion
chlorimine
shortacting
alkylating
agent
experience
five
cases
a
method
discussed
providing
palliative
treatment
patients
nonresectable
lung
cancer
means
administering
a
shortacting
alkylating
agent
upper
half
body
temporarily
occluding
circulation
lower
half
body
proper
selection
patients
awareness
potential
complications
procedure
appears
safe
effective
